Lazard Frères Gestion’s Thermo Fisher Scientific TMO Stock Holding History

Lazard Frères Gestion’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-544	Closed	-$289K	–	82
2023 Q4	$289K	Hold	544	–	–	0.01%	73
2023 Q3	$273K	Hold	544	–	–	0.01%	73
2023 Q2	$279K	Hold	544	–	–	0.01%	72
2023 Q1	$258K	Buy	+544	New	+$307K	0.01%	71

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Lazard Frères Gestion's TMO Position: Q1 2024 in Review

Lazard Frères Gestion sold out of Thermo Fisher Scientific (TMO) in Q1 2024, closing a stake of 544 shares — an estimated $289K sold.

Lazard Frères Gestion first reported a position in TMO in Q1 2023 and held it in 4 quarters. The position peaked at $289K in Q4 2023. 2,527 funds tracked by Wall St. Rank hold TMO as of Q1 2024.

Lazard Frères Gestion reported no remaining Thermo Fisher Scientific position as of Q1 2024 after selling out during the quarter.
Lazard Frères Gestion sold 544 Thermo Fisher Scientific shares in Q1 2024, an estimated $289K.
Lazard Frères Gestion first reported a position in Thermo Fisher Scientific in Q1 2023 and held it in 4 quarters.
Lazard Frères Gestion's Thermo Fisher Scientific position peaked at $289K in Q4 2023.
2,527 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2024.

Based on Lazard Frères Gestion's 13F filing for Q1 2024, filed 10 May 2024.